Cargando…
Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis
Autores principales: | Warren, R.B., Barker, J.N.W., Van de Kerkhof, P., Reich, K., Mrowietz, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851748/ https://www.ncbi.nlm.nih.gov/pubmed/31033034 http://dx.doi.org/10.1111/jdv.15644 |
Ejemplares similares
-
Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: Results of a prospective study
por: Falkvoll, Sandra, et al.
Publicado: (2019) -
Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study
por: van de Kerkhof, P.C.M., et al.
Publicado: (2019) -
Fumaric acid esters in the management of psoriasis
por: Balak, Deepak MW
Publicado: (2015) -
Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF)
por: Eppinga, Hester, et al.
Publicado: (2017) -
Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis
por: Hoepner, Robert, et al.
Publicado: (2015)